Cytogenetic alterations in chagasic achalasia compared to esophageal carcinoma

被引:21
作者
Manoel-Caetano, FD
Borim, AA
Caetano, A
Cury, PM
Silva, AE
机构
[1] Univ Estadual Paulista, Dept Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil
[2] Hosp Base, Fac Med, Sao Paulo, Brazil
关键词
D O I
10.1016/S0165-4608(03)00274-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients with chagasic achalasia (megaesophagus) are liable to have an additional 1.7-20% possibility of developing esophageal squamous cell carcinoma (ESCC). We applied a fluorescence in situ hybridization technique in 20 such patients and found aneuploidies of chromosomes 7, 11, and 17 in 60% (12 of 20 specimens) and deletion of the TP53 gene in 54.5% (6 of 11 specimens; it was only possible to obtain data by FISH technique from 11 of the 20 achalasia patients). The main aneuploidies detected were chromosome 7 monosomy or trisomy (35%) in mid-third megaesophagus cases, and chromosome 17 monosomy or trisomy (25%) in distal-third cases. TP53 gene deletion was more frequent in mid-third (62.5%) than in distal-third megaesophagus cases (40%). In chagasic megaesophagus, no amplification of the cyclin D1 gene (CCND1) was observed. Comparing chagasic megaesophagus to ESCC, we found a higher frequency of aneuploidies in all 10 tumors. The main alterations were trisomy or tetrasomy of chromosomes 17 (90%), 11 (70%), and 7 (70%). Amplification of CCND1 was evidenced as a cluster in 70% of the tumors (22-99% of nuclei), while TP53 gene deletion occurred in 100%. To our knowledge, this is the first cytogenetic analysis of chagasic megaesophagus to show that aneuploidies of chromosomes 7, 11, and 17, and TP53 gene deletion might be related to increased risk for malignancy. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 39 条
[1]   ESOPHAGEAL CANCER AND AMPLIFICATION OF THE HUMAN CYCLIN-D GENE CCND1/PRAD1 [J].
ADELAIDE, J ;
MONGES, G ;
DERDERIAN, C ;
SEITZ, JF ;
BIRNBAUM, D .
BRITISH JOURNAL OF CANCER, 1995, 71 (01) :64-68
[2]   Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach [J].
Arber, N ;
Gammon, MD ;
Hibshoosh, H ;
Britton, JA ;
Zhang, Y ;
Schonberg, JB ;
Roterdam, H ;
Fabian, I ;
Holt, PR ;
Weinstein, IB .
HUMAN PATHOLOGY, 1999, 30 (09) :1087-1092
[3]  
Bektas A, 2001, HEPATO-GASTROENTEROL, V48, P408
[4]  
Brücher BLDM, 2001, WORLD J SURG, V25, P745
[5]  
Chino O, 2000, ANTICANCER RES, V20, P3717
[6]  
Du Plessis L, 1999, CANCER RES, V59, P1877
[7]   Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells [J].
Eastmond, DA ;
Schuler, M ;
Rupa, DS .
MUTATION RESEARCH LETTERS, 1995, 348 (04) :153-162
[8]  
Franca S. B., 1996, Revista da Sociedade Brasileira de Medicina Tropical, V29, P109, DOI 10.1590/S0037-86821996000200003
[9]   Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas [J].
Hirsch, FR ;
Varella-Garcia, M ;
Franklin, WA ;
Veve, R ;
Chen, L ;
Helfrich, B ;
Zeng, C ;
Baron, A ;
Bunn, PA .
BRITISH JOURNAL OF CANCER, 2002, 86 (09) :1449-1456
[10]  
Hu N, 2001, CLIN CANCER RES, V7, P883